AGEN
Price
$5.36
Change
-$0.16 (-2.90%)
Updated
Aug 1 closing price
Capitalization
146.95M
CTMX
Price
$2.35
Change
+$0.16 (+7.31%)
Updated
Aug 1 closing price
Capitalization
368.65M
5 days until earnings call
Interact to see
Advertisement

AGEN vs CTMX

Header iconAGEN vs CTMX Comparison
Open Charts AGEN vs CTMXBanner chart's image
Agenus
Price$5.36
Change-$0.16 (-2.90%)
Volume$269.14K
Capitalization146.95M
CytomX Therapeutics
Price$2.35
Change+$0.16 (+7.31%)
Volume$1.45M
Capitalization368.65M
AGEN vs CTMX Comparison Chart in %
Loading...
AGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CTMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Incyte Corp (NASDAQ:INCY), Moderna (NASDAQ:MRNA), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), BioCryst Pharmaceuticals (NASDAQ:BCRX), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Sarepta Therapeutics (NASDAQ:SRPT), Novavax (NASDAQ:NVAX), Nektar Therapeutics (NASDAQ:NKTR).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.34B. The market cap for tickers in the group ranges from 58 to 213.98B. NONOF holds the highest valuation in this group at 213.98B. The lowest valued company is SEELQ at 58.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 1%. For the same Industry, the average monthly price growth was 17%, and the average quarterly price growth was 37%. SLXN experienced the highest price growth at 1,575%, while ADAP experienced the biggest fall at -76%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was -7%. For the same stocks of the Industry, the average monthly volume growth was 38% and the average quarterly volume growth was 123%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 83
Price Growth Rating: 57
SMR Rating: 92
Profit Risk Rating: 95
Seasonality Score: -11 (-100 ... +100)

Market Cap

The average market capitalization across the group is 253.39M. The market cap for tickers in the group ranges from 161.76M to 345.02M. CTMX holds the highest valuation in this group at 345.02M. The lowest valued company is AGEN at 161.76M.

High and low price notable news

The average weekly price growth across all stocks in the group was -9%. For the same group, the average monthly price growth was 3%, and the average quarterly price growth was 101%. CTMX experienced the highest price growth at -8%, while AGEN experienced the biggest fall at -9%.

Volume

The average weekly volume growth across all stocks in the group was 74%. For the same stocks of the group, the average monthly volume growth was -40% and the average quarterly volume growth was 95%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 83
P/E Growth Rating: 90
Price Growth Rating: 35
SMR Rating: 99
Profit Risk Rating: 100
Seasonality Score: 0 (-100 ... +100)
VS
AGEN vs. CTMX commentary
Aug 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGEN is a StrongBuy and CTMX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 02, 2025
Stock price -- (AGEN: $5.49 vs. CTMX: $2.19)
Brand notoriety: AGEN and CTMX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGEN: 46% vs. CTMX: 77%
Market capitalization -- AGEN: $146.95M vs. CTMX: $368.65M
AGEN [@Biotechnology] is valued at $146.95M. CTMX’s [@Biotechnology] market capitalization is $368.65M. The market cap for tickers in the [@Biotechnology] industry ranges from $213.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGEN’s FA Score shows that 0 FA rating(s) are green whileCTMX’s FA Score has 0 green FA rating(s).

  • AGEN’s FA Score: 0 green, 5 red.
  • CTMX’s FA Score: 0 green, 5 red.
According to our system of comparison, both AGEN and CTMX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGEN’s TA Score shows that 3 TA indicator(s) are bullish while CTMX’s TA Score has 3 bullish TA indicator(s).

  • AGEN’s TA Score: 3 bullish, 4 bearish.
  • CTMX’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, both AGEN and CTMX are a bad buy in the short-term.

Price Growth

AGEN (@Biotechnology) experienced а -9.11% price change this week, while CTMX (@Biotechnology) price change was -8.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.32%. For the same industry, the average monthly price growth was +16.82%, and the average quarterly price growth was +37.20%.

Reported Earning Dates

AGEN is expected to report earnings on May 12, 2025.

CTMX is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+1.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CTMX($369M) has a higher market cap than AGEN($147M). CTMX has higher P/E ratio than AGEN: CTMX (4.88) vs AGEN (0.18). CTMX YTD gains are higher at: 112.621 vs. AGEN (100.365). CTMX has higher annual earnings (EBITDA): 37.6M vs. AGEN (-81.06M). CTMX has more cash in the bank: 79.9M vs. AGEN (18.5M). CTMX has less debt than AGEN: CTMX (8.15M) vs AGEN (92M). CTMX has higher revenues than AGEN: CTMX (148M) vs AGEN (99.5M).
AGENCTMXAGEN / CTMX
Capitalization147M369M40%
EBITDA-81.06M37.6M-216%
Gain YTD100.365112.62189%
P/E Ratio0.184.884%
Revenue99.5M148M67%
Total Cash18.5M79.9M23%
Total Debt92M8.15M1,129%
FUNDAMENTALS RATINGS
AGEN vs CTMX: Fundamental Ratings
AGEN
CTMX
OUTLOOK RATING
1..100
7782
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
70
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
3635
P/E GROWTH RATING
1..100
9784
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CTMX's Valuation (70) in the Biotechnology industry is in the same range as AGEN (97). This means that CTMX’s stock grew similarly to AGEN’s over the last 12 months.

CTMX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as AGEN (100). This means that CTMX’s stock grew similarly to AGEN’s over the last 12 months.

CTMX's SMR Rating (98) in the Biotechnology industry is in the same range as AGEN (100). This means that CTMX’s stock grew similarly to AGEN’s over the last 12 months.

CTMX's Price Growth Rating (35) in the Biotechnology industry is in the same range as AGEN (36). This means that CTMX’s stock grew similarly to AGEN’s over the last 12 months.

CTMX's P/E Growth Rating (84) in the Biotechnology industry is in the same range as AGEN (97). This means that CTMX’s stock grew similarly to AGEN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AGENCTMX
RSI
ODDS (%)
Bearish Trend 2 days ago
82%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 16 days ago
84%
Bullish Trend 23 days ago
76%
Declines
ODDS (%)
Bearish Trend 8 days ago
88%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
AGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CTMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GPAGF17.59N/A
N/A
Gruma S.A.B. de CV
HPTO0.05N/A
N/A
hopTo Inc.
SLGYF0.30N/A
N/A
San Leon Energy Plc
MONSF71.23N/A
N/A
MONTEA SICAFI
DHLGY45.01-0.44
-0.97%
Deutsche Post AG

AGEN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AGEN has been closely correlated with TAOX. These tickers have moved in lockstep 91% of the time. This A.I.-generated data suggests there is a high statistical probability that if AGEN jumps, then TAOX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGEN
1D Price
Change %
AGEN100%
-6.95%
TAOX - AGEN
91%
Closely correlated
-6.08%
ALLR - AGEN
87%
Closely correlated
-3.67%
NRXP - AGEN
83%
Closely correlated
-5.34%
PALI - AGEN
81%
Closely correlated
-2.75%
CCCC - AGEN
43%
Loosely correlated
-5.09%
More

CTMX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CTMX has been loosely correlated with MLEC. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CTMX jumps, then MLEC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTMX
1D Price
Change %
CTMX100%
-5.60%
MLEC - CTMX
42%
Loosely correlated
+0.63%
BCAB - CTMX
37%
Loosely correlated
-1.07%
VCYT - CTMX
36%
Loosely correlated
-1.92%
CRNX - CTMX
36%
Loosely correlated
-2.26%
HOWL - CTMX
35%
Loosely correlated
+0.83%
More